| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.777 | 0.004 | 0.777 | 5 Hydroxytryptamine release stimulant | 0.718 0.006 CID_154699906 | ||
| 0.649 | 0.005 | 0.649 | Psychostimulant | 0.623 0.005 CID_154699906 | ||
| 0.607 | 0.003 | 0.607 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.583 | 0.004 | 0.583 | 5 Hydroxytryptamine 1 agonist | 0.08 0.025 CID_154699906 | ||
| 0.576 | 0.003 | 0.576 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.578 | 0.01 | 0.578 | GABA C receptor rho-3 antagonist | |||
| 0.567 | 0.004 | 0.567 | 5 Hydroxytryptamine agonist | 0.084 0.04 CID_154699906 | ||
| 0.552 | 0.003 | 0.552 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.566 | 0.024 | 0.566 | Aldehyde oxidase inhibitor | |||
| 0.527 | 0.05 | 0.527 | Caspase 9 stimulant | 0.486 0.065 CID_154699906 | ||
| 0.48 | 0.036 | 0.48 | Calcium channel L-type activator | 0.349 0.118 CID_154699906 | ||
| 0.448 | 0.004 | 0.448 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.451 | 0.014 | 0.451 | Peroxidase inhibitor | |||
| 0.434 | 0.002 | 0.434 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.081 CID_154699906 | ||
| 0.431 | 0.007 | 0.431 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.436 | 0.026 | 0.436 | Interleukin antagonist | 0.264 0.057 CID_154699906 | ||
| 0.405 | 0.002 | 0.405 | Prolactin inhibitor | 0.082 0.078 CID_154699906 | ||
| 0.375 | 0.003 | 0.375 | Histamine N-methyltransferase inhibitor | 0.13 0.023 CID_154699906 | ||
| 0.429 | 0.061 | 0.511 | Histamine release inhibitor | 0.511 0.025 CID_154699906 | CID_154699906 | |
| 0.435 | 0.072 | 0.435 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.393 | 0.03 | 0.393 | DNA damaging | 0.388 0.031 CID_154699906 | ||
| 0.365 | 0.004 | 0.365 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.409 | 0.052 | 0.409 | Vasodilator, peripheral | 0.404 0.054 CID_154699906 | ||
| 0.382 | 0.028 | 0.382 | Amyloid beta aggregation inhibitor | 0.237 0.062 CID_154699906 | ||
| 0.36 | 0.008 | 0.36 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.356 | 0.004 | 0.356 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.376 | 0.027 | 0.376 | Insulysin inhibitor | |||
| 0.348 | 0.003 | 0.348 | Myeloperoxidase inhibitor | |||
| 0.352 | 0.007 | 0.352 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.347 | 0.004 | 0.347 | 5 Hydroxytryptamine 1B agonist | 0.07 0.017 CID_154699906 | ||
| 0.349 | 0.014 | 0.349 | 5 Hydroxytryptamine antagonist | |||
| 0.34 | 0.013 | 0.34 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.391 | 0.078 | 0.391 | 15-Lipoxygenase inhibitor | |||
| 0.359 | 0.05 | 0.496 | Spasmolytic | 0.496 0.023 CID_154699906 | CID_154699906 | |
| 0.302 | 0.003 | 0.302 | 5 Hydroxytryptamine 2A agonist | |||
| 0.353 | 0.054 | 0.554 | Vasodilator, coronary | 0.554 0.01 CID_154699906 | CID_154699906 | |
| 0.336 | 0.042 | 0.336 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.301 | 0.009 | 0.301 | Alpha 2b adrenoreceptor antagonist | |||
| 0.276 | 0.008 | 0.276 | GABA C receptor rho-2 antagonist | |||
| 0.301 | 0.033 | 0.301 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.275 | 0.01 | 0.275 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.268 | 0.013 | 0.268 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.286 | 0.032 | 0.429 | DNA methylase inhibitor | 0.429 0.009 CID_154699906 | CID_154699906 | |
| 0.258 | 0.005 | 0.258 | CF transmembrane conductance regulator agonist | 0.167 0.05 CID_154699906 | ||
| 0.344 | 0.097 | 0.344 | MAP kinase kinase 6 inhibitor | |||
| 0.277 | 0.035 | 0.382 | DNA methyltransferase I inhibitor | 0.382 0.01 CID_154699906 | CID_154699906 | |
| 0.317 | 0.076 | 0.317 | Calcium channel activator | |||
| 0.259 | 0.02 | 0.259 | Nav1.2 sodium channel blocker | |||
| 0.302 | 0.065 | 0.302 | Hypoxia-inducible factor 1 alpha inhibitor | 0.289 0.071 CID_154699906 | ||
| 0.259 | 0.027 | 0.259 | Nitric-oxide synthase stimulant | 0.252 0.031 CID_154699906 | ||
| 0.257 | 0.031 | 0.257 | Lipocortins synthesis antagonist | 0.22 0.045 CID_154699906 | ||
| 0.228 | 0.008 | 0.228 | GABA C receptor antagonist | |||
| 0.239 | 0.022 | 0.239 | MAO A inhibitor | |||
| 0.223 | 0.009 | 0.223 | 5 Hydroxytryptamine 3A agonist | |||
| 0.237 | 0.023 | 0.237 | Neurotensin receptor agonist | |||
| 0.229 | 0.021 | 0.229 | Adenylate cyclase inhibitor | 0.155 0.042 CID_154699906 | ||
| 0.248 | 0.043 | 0.248 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.146 CID_154699906 | ||
| 0.213 | 0.012 | 0.213 | Protein kinase C gamma inhibitor | |||
| 0.21 | 0.01 | 0.21 | Adenylate cyclase stimulant | 0.16 0.047 CID_154699906 | ||
| 0.206 | 0.006 | 0.206 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.21 | 0.016 | 0.21 | Alpha 2c adrenoreceptor antagonist | |||
| 0.19 | 0.004 | 0.19 | 5 Hydroxytryptamine 2 agonist | |||
| 0.196 | 0.012 | 0.196 | Protein kinase C zeta inhibitor | |||
| 0.195 | 0.014 | 0.25 | Photosensitizer | 0.25 0.006 CID_154699906 | CID_154699906 | |
| 0.254 | 0.075 | 0.254 | Gastrin inhibitor | 0.184 0.173 CID_154699906 | ||
| 0.202 | 0.025 | 0.214 | DNA intercalator | 0.214 0.022 CID_154699906 | CID_154699906 | |
| 0.241 | 0.065 | 0.241 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.18 | 0.004 | 0.18 | 5 Hydroxytryptamine 7 agonist | |||
| 0.191 | 0.015 | 0.191 | Alpha 2a adrenoreceptor antagonist | |||
| 0.245 | 0.071 | 0.481 | Free radical scavenger | 0.481 0.018 CID_154699906 | CID_154699906 | |
| 0.188 | 0.016 | 0.188 | NMDA receptor antagonist | |||
| 0.172 | 0.003 | 0.172 | 5 Hydroxytryptamine 1D agonist | |||
| 0.237 | 0.07 | 0.377 | Cyclic AMP phosphodiesterase inhibitor | 0.377 0.02 CID_154699906 | CID_154699906 | |
| 0.205 | 0.039 | 0.205 | MAO inhibitor | |||
| 0.178 | 0.012 | 0.178 | GABA C receptor rho-1 antagonist | |||
| 0.184 | 0.02 | 0.184 | Alpha 2 adrenoreceptor antagonist | |||
| 0.186 | 0.022 | 0.186 | Falcipain 3 inhibitor | |||
| 0.24 | 0.076 | 0.301 | Antiamyloidogenic | 0.301 0.051 CID_154699906 | CID_154699906 | |
| 0.186 | 0.025 | 0.186 | Nav1.6 sodium channel blocker | |||
| 0.319 | 0.159 | 0.516 | Apoptosis agonist | 0.516 0.069 CID_154699906 | CID_154699906 | |
| 0.178 | 0.02 | 0.178 | Carbonic anhydrase III inhibitor | 0.092 0.072 CID_154699906 | ||
| 0.161 | 0.004 | 0.161 | 5 Hydroxytryptamine 3 agonist | |||
| 0.155 | 0.005 | 0.155 | Beta 3 adrenoreceptor antagonist | |||
| 0.188 | 0.038 | 0.188 | NADPH oxidase inhibitor | 0.128 0.073 CID_154699906 | ||
| 0.151 | 0.003 | 0.151 | Dopamine autoreceptor agonist | |||
| 0.238 | 0.091 | 0.521 | Antioxidant | 0.521 0.018 CID_154699906 | CID_154699906 | |
| 0.156 | 0.013 | 0.156 | Adrenaline agonist | |||
| 0.18 | 0.038 | 0.18 | Neurotrophic factor | 0.155 0.055 CID_154699906 | ||
| 0.211 | 0.07 | 0.211 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.174 | 0.033 | 0.264 | Topoisomerase I inhibitor | 0.264 0.015 CID_154699906 | CID_154699906 | |
| 0.147 | 0.007 | 0.147 | NMDA 2A receptor antagonist | |||
| 0.257 | 0.121 | 0.417 | Apoptosis antagonist | 0.417 0.034 CID_154699906 | CID_154699906 | |
| 0.174 | 0.038 | 0.174 | Toll-Like receptor 2 antagonist | |||
| 0.153 | 0.018 | 0.153 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.142 | 0.007 | 0.142 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.161 | 0.027 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.024 CID_154699906 | CID_154699906 | |
| 0.185 | 0.05 | 0.185 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.165 | 0.031 | 0.165 | Chelator | |||
| 0.236 | 0.102 | 0.518 | Immunostimulant | 0.518 0.027 CID_154699906 | CID_154699906 | |
| 0.148 | 0.015 | 0.148 | Dopamine D1 antagonist | |||
| 0.222 | 0.091 | 0.222 | Aryl hydrocarbon receptor agonist | |||
| 0.193 | 0.064 | 0.193 | Sigma receptor agonist | |||
| 0.18 | 0.052 | 0.18 | Acetylcholine M1 receptor antagonist | |||
| 0.145 | 0.017 | 0.145 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.142 | 0.015 | 0.142 | Somatostatin 1 agonist | 0.09 0.042 CID_154699906 | ||
| 0.144 | 0.018 | 0.144 | NMDA 2 receptor antagonist | |||
| 0.135 | 0.012 | 0.167 | Glycine receptor antagonist | 0.167 0.005 CID_154699906 | CID_154699906 | |
| 0.249 | 0.128 | 0.547 | Transcription factor NF kappa B inhibitor | 0.547 0.038 CID_154699906 | CID_154699906 | |
| 0.14 | 0.022 | 0.14 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.134 | 0.017 | 0.134 | Dopamine agonist | |||
| 0.125 | 0.008 | 0.125 | Estrogen-related receptor beta agonist | |||
| 0.151 | 0.035 | 0.151 | GABA receptor agonist | |||
| 0.226 | 0.109 | 0.226 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.142 | 0.027 | 0.142 | Dopamine antagonist | |||
| 0.139 | 0.024 | 0.139 | Dopamine D2 antagonist | |||
| 0.215 | 0.101 | 0.369 | DNA synthesis inhibitor | 0.369 0.026 CID_154699906 | CID_154699906 | |
| 0.134 | 0.025 | 0.134 | Acetylcholine nicotinic antagonist | |||
| 0.131 | 0.022 | 0.131 | CYP2A6 inhibitor | |||
| 0.192 | 0.086 | 0.192 | Pyruvate kinase inhibitor | |||
| 0.136 | 0.03 | 0.136 | DOPA decarboxylase inhibitor | |||
| 0.151 | 0.046 | 0.247 | Alkylator | 0.247 0.017 CID_154699906 | CID_154699906 | |
| 0.142 | 0.037 | 0.142 | GABA C receptor agonist | |||
| 0.113 | 0.009 | 0.113 | Dopamine D2 agonist | 0.052 0.025 CID_154699906 | ||
| 0.122 | 0.023 | 0.153 | Phosphodiesterase 6D inhibitor | 0.153 0.009 CID_154699906 | CID_154699906 | |
| 0.132 | 0.033 | 0.132 | Sphingomyelinase inhibitor | 0.095 0.065 CID_154699906 | ||
| 0.148 | 0.05 | 0.245 | Topoisomerase II inhibitor | 0.245 0.025 CID_154699906 | CID_154699906 | |
| 0.138 | 0.041 | 0.138 | Alpha adrenoreceptor antagonist | |||
| 0.218 | 0.121 | 0.218 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.159 | 0.063 | 0.251 | Lipid peroxidase inhibitor | 0.251 0.027 CID_154699906 | CID_154699906 | |
| 0.115 | 0.019 | 0.115 | Neuronal nicotinic receptor antagonist | |||
| 0.111 | 0.018 | 0.111 | Viral attachment inhibitor | 0.084 0.041 CID_154699906 | ||
| 0.115 | 0.023 | 0.115 | Alpha adrenoreceptor agonist | |||
| 0.136 | 0.045 | 0.136 | Interleukin 8 antagonist | |||
| 0.104 | 0.014 | 0.104 | GABA B receptor agonist | |||
| 0.125 | 0.035 | 0.125 | Antineoplastic alkaloid | |||
| 0.094 | 0.005 | 0.094 | Adenylate cyclase 1 inhibitor | |||
| 0.093 | 0.005 | 0.093 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.219 | 0.131 | 0.219 | 12-Lipoxygenase inhibitor | |||
| 0.126 | 0.039 | 0.126 | Adenylate kinase inhibitor | 0.105 0.06 CID_154699906 | ||
| 0.195 | 0.108 | 0.319 | Vasodilator | 0.319 0.042 CID_154699906 | CID_154699906 | |
| 0.129 | 0.043 | 0.129 | Butyrylcholinesterase inhibitor | |||
| 0.104 | 0.018 | 0.104 | CC chemokine 5 receptor agonist | |||
| 0.089 | 0.003 | 0.089 | 5 Hydroxytryptamine 6 agonist | |||
| 0.13 | 0.044 | 0.13 | Nav1.4 sodium channel blocker | |||
| 0.18 | 0.094 | 0.18 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.142 | 0.057 | 0.142 | Cholinergic antagonist | |||
| 0.145 | 0.061 | 0.145 | Interleukin 1 antagonist | |||
| 0.097 | 0.013 | 0.097 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.162 | 0.078 | 0.162 | Growth hormone agonist | |||
| 0.099 | 0.017 | 0.099 | Beta adrenoreceptor antagonist | |||
| 0.124 | 0.043 | 0.124 | Carbonic anhydrase XV inhibitor | |||
| 0.092 | 0.011 | 0.092 | Cyclin D1 inhibitor | |||
| 0.141 | 0.061 | 0.141 | Acetylcholinesterase inhibitor | |||
| 0.152 | 0.073 | 0.152 | Heat shock protein 90 antagonist | |||
| 0.137 | 0.059 | 0.137 | Antibacterial (Helicobacter pylori) | |||
| 0.136 | 0.058 | 0.136 | Acetylcholine antagonist | |||
| 0.093 | 0.017 | 0.093 | 5 Hydroxytryptamine 1A agonist | |||
| 0.197 | 0.122 | 0.197 | Cardiotonic | |||
| 0.133 | 0.06 | 0.133 | Nav1.3 sodium channel blocker | |||
| 0.119 | 0.048 | 0.279 | Mediator release inhibitor | 0.279 0.008 CID_154699906 | CID_154699906 | |
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | |||
| 0.119 | 0.05 | 0.266 | AMP-activated protein kinase stimulant | 0.266 0.006 CID_154699906 | CID_154699906 | |
| 0.085 | 0.015 | 0.085 | Beta 1 adrenoreceptor antagonist | |||
| 0.159 | 0.089 | 0.159 | LIM domain kinase 1 inhibitor | |||
| 0.114 | 0.045 | 0.114 | Creatine kinase inhibitor | |||
| 0.187 | 0.118 | 0.364 | Peptidyltransferase inhibitor | 0.364 0.01 CID_154699906 | CID_154699906 | |
| 0.188 | 0.119 | 0.188 | RNA-directed DNA polymerase inhibitor | |||
| 0.08 | 0.011 | 0.08 | Prolactin release inhibitor | |||
| 0.247 | 0.179 | 0.612 | Antibacterial | 0.612 0.018 CID_154699906 | CID_154699906 | |
| 0.115 | 0.047 | 0.115 | Antiadrenergic | |||
| 0.143 | 0.076 | 0.143 | MAP kinase kinase 4 inhibitor | |||
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.195 | 0.129 | 0.195 | Neuropeptide Y2 antagonist | |||
| 0.111 | 0.048 | 0.111 | Adrenaline antagonist | |||
| 0.086 | 0.023 | 0.086 | Protein kinase C beta inhibitor | |||
| 0.127 | 0.064 | 0.127 | Aldehyde dehydrogenase inhibitor | 0.111 0.082 CID_154699906 | ||
| 0.101 | 0.039 | 0.101 | Carbonic anhydrase VI inhibitor | |||
| 0.121 | 0.059 | 0.121 | Transcription factor STAT6 inhibitor | |||
| 0.066 | 0.005 | 0.066 | Melatonin receptor 1A agonist | |||
| 0.099 | 0.038 | 0.099 | GABA A receptor agonist | |||
| 0.155 | 0.094 | 0.277 | ATPase inhibitor | 0.277 0.009 CID_154699906 | CID_154699906 | |
| 0.074 | 0.014 | 0.074 | Beta 2 adrenoreceptor agonist | |||
| 0.096 | 0.037 | 0.096 | Alpha 1b adrenoreceptor antagonist | |||
| 0.073 | 0.014 | 0.073 | Cholecystokinin A antagonist | |||
| 0.08 | 0.024 | 0.08 | Alpha 2 adrenoreceptor agonist | |||
| 0.167 | 0.111 | 0.167 | Insulin sensitizer | |||
| 0.111 | 0.055 | 0.111 | MAO B inhibitor | |||
| 0.111 | 0.055 | 0.225 | Beta glucuronidase inhibitor | 0.225 0.01 CID_154699906 | CID_154699906 | |
| 0.081 | 0.025 | 0.081 | Bombesin 1 receptor agonist | |||
| 0.144 | 0.09 | 0.219 | Melanin inhibitor | 0.219 0.035 CID_154699906 | CID_154699906 | |
| 0.071 | 0.016 | 0.071 | Beta 2 adrenoreceptor antagonist | |||
| 0.158 | 0.105 | 0.159 | Anesthetic general | 0.159 0.104 CID_154699906 | CID_154699906 | |
| 0.058 | 0.005 | 0.058 | Urotensin II agonist | |||
| 0.086 | 0.034 | 0.086 | HIV-1 integrase inhibitor | |||
| 0.067 | 0.015 | 0.067 | Cholecystokinin antagonist | |||
| 0.164 | 0.112 | 0.164 | Growth factor agonist | |||
| 0.06 | 0.008 | 0.06 | 5 Hydroxytryptamine 2B agonist | |||
| 0.063 | 0.011 | 0.063 | Somatostatin 4 agonist | |||
| 0.075 | 0.027 | 0.075 | Acetylcholine M5 receptor antagonist | |||
| 0.065 | 0.017 | 0.065 | NMDA receptor subunit 3B antagonist | |||
| 0.072 | 0.024 | 0.072 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.057 | 0.009 | 0.057 | Bombesin 1 receptor antagonist | |||
| 0.072 | 0.026 | 0.072 | Heat shock protein 90 beta antagonist | |||
| 0.145 | 0.099 | 0.145 | Dual specificity phosphatase inhibitor | |||
| 0.211 | 0.164 | 0.631 | Antithrombotic | 0.631 0.013 CID_154699906 | CID_154699906 | |
| 0.076 | 0.03 | 0.076 | Aryl hydrocarbon receptor antagonist | |||
| 0.136 | 0.09 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.132 0.112 CID_154699906 | ||
| 0.072 | 0.027 | 0.072 | Protein kinase C eta inhibitor | 0.049 0.046 CID_154699906 | ||
| 0.052 | 0.009 | 0.052 | Melatonin 1 agonist | 0.035 0.02 CID_154699906 | ||
| 0.048 | 0.005 | 0.048 | 5 Hydroxytryptamine 1F agonist | |||
| 0.055 | 0.012 | 0.055 | Histamine H1 receptor agonist | |||
| 0.101 | 0.058 | 0.101 | Nitric-oxide synthase inhibitor | |||
| 0.137 | 0.094 | 0.137 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.058 | 0.016 | 0.058 | Histone deacetylase 7 inhibitor | |||
| 0.162 | 0.121 | 0.162 | Neurotrophic factor enhancer | |||
| 0.094 | 0.053 | 0.094 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.056 | 0.015 | 0.056 | GHS receptor agonist | |||
| 0.138 | 0.098 | 0.138 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.122 | 0.082 | 0.122 | Vanilloid 1 agonist | 0.116 0.098 CID_154699906 | ||
| 0.109 | 0.069 | 0.111 | Acetylcholine release stimulant | 0.111 0.063 CID_154699906 | CID_154699906 | |
| 0.083 | 0.043 | 0.083 | Acetylcholine M4 receptor antagonist | |||
| 0.053 | 0.014 | 0.053 | Histone deacetylase 9 inhibitor | |||
| 0.087 | 0.049 | 0.087 | Alpha 1 adrenoreceptor antagonist | |||
| 0.055 | 0.018 | 0.055 | Somatostatin 1 antagonist | |||
| 0.052 | 0.015 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.101 | 0.065 | 0.101 | Gastric antisecretory | |||
| 0.11 | 0.075 | 0.11 | Estrogen antagonist | |||
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | |||
| 0.094 | 0.058 | 0.094 | Protein kinase C delta inhibitor | |||
| 0.046 | 0.011 | 0.046 | Melatonin agonist | |||
| 0.084 | 0.05 | 0.155 | Topoisomerase II alpha inhibitor | 0.155 0.022 CID_154699906 | CID_154699906 | |
| 0.053 | 0.02 | 0.053 | Geranyltranstransferase inhibitor | |||
| 0.129 | 0.096 | 0.129 | Cholinergic | |||
| 0.058 | 0.026 | 0.058 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.05 | 0.02 | 0.05 | NMDA receptor subunit 3A antagonist | |||
| 0.135 | 0.104 | 0.135 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.05 | 0.02 | 0.05 | GABA B receptor antagonist | |||
| 0.051 | 0.021 | 0.051 | Histamine H2 receptor agonist | |||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | |||
| 0.054 | 0.024 | 0.054 | Bombesin antagonist | |||
| 0.068 | 0.039 | 0.068 | Dopamine D3 antagonist | |||
| 0.078 | 0.049 | 0.078 | Porphobilinogen synthase inhibitor | |||
| 0.091 | 0.063 | 0.091 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.153 | 0.126 | 0.153 | Anticonvulsant | |||
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | |||
| 0.075 | 0.048 | 0.075 | Alpha 1a adrenoreceptor antagonist | |||
| 0.042 | 0.016 | 0.042 | Somatostatin agonist | |||
| 0.035 | 0.009 | 0.035 | Estrogen-related receptor gamma antagonist | |||
| 0.064 | 0.038 | 0.064 | Alpha 1d adrenoreceptor antagonist | |||
| 0.065 | 0.039 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.039 | 0.013 | 0.039 | Sigma 2 receptor antagonist | |||
| 0.085 | 0.059 | 0.085 | Calcium antagonist | |||
| 0.033 | 0.007 | 0.033 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 CID_154699906 | ||
| 0.04 | 0.015 | 0.04 | Melatonin 2 agonist | 0.033 0.023 CID_154699906 | ||
| 0.072 | 0.048 | 0.072 | Benzodiazepine agonist | |||
| 0.06 | 0.035 | 0.06 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.027 | 0.005 | 0.027 | Estrogen-related receptor gamma agonist | |||
| 0.067 | 0.046 | 0.067 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.042 | 0.022 | 0.042 | Cholecystokinin B agonist | |||
| 0.064 | 0.045 | 0.064 | CDC25B inhibitor | |||
| 0.033 | 0.014 | 0.033 | Melatonin antagonist | |||
| 0.094 | 0.074 | 0.094 | Nav1.1 sodium channel blocker | |||
| 0.143 | 0.124 | 0.143 | Catenin beta inhibitor | |||
| 0.036 | 0.017 | 0.036 | Cholecystokinin B antagonist | |||
| 0.162 | 0.143 | 0.382 | Tumour necrosis factor alpha release inhibitor | 0.382 0.03 CID_154699906 | CID_154699906 | |
| 0.035 | 0.017 | 0.035 | Protein kinase C beta I inhibitor | 0.034 0.021 CID_154699906 | ||
| 0.155 | 0.137 | 0.155 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.044 | 0.026 | 0.044 | Growth hormone release inhibitor | |||
| 0.024 | 0.007 | 0.024 | Follicle-stimulating hormone antagonist | |||
| 0.168 | 0.151 | 0.168 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.049 | 0.032 | 0.049 | AMPA receptor antagonist | |||
| 0.05 | 0.033 | 0.05 | Topoisomerase II beta inhibitor | |||
| 0.052 | 0.036 | 0.052 | Vanilloid 2 antagonist | |||
| 0.123 | 0.108 | 0.123 | MAP3K9 inhibitor | |||
| 0.112 | 0.097 | 0.112 | Interleukin 4 antagonist | 0.108 0.104 CID_154699906 | ||
| 0.142 | 0.128 | 0.586 | Angiogenesis stimulant | 0.586 0.007 CID_154699906 | CID_154699906 | |
| 0.056 | 0.041 | 0.056 | Alpha 1 adrenoreceptor agonist | |||
| 0.142 | 0.127 | 0.142 | Death-associated protein kinase 2 inhibitor | |||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.097 | 0.086 | 0.097 | Anesthetic local | |||
| 0.127 | 0.116 | 0.127 | Heat shock protein 90 alpha antagonist | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.079 | 0.071 | 0.079 | D-Ala-D-Ala ligase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Estrogen-related receptor beta antagonist | |||
| 0.087 | 0.079 | 0.087 | Alpha 2d adrenoreceptor antagonist | |||
| 0.098 | 0.091 | 0.098 | Cholesterol synthesis inhibitor | |||
| 0.022 | 0.016 | 0.022 | Follicle-stimulating hormone agonist | |||
| 0.033 | 0.027 | 0.033 | Somatostatin 5 agonist | |||
| 0.039 | 0.033 | 0.039 | Dopamine D5 antagonist | |||
| 0.104 | 0.098 | 0.104 | Tubulin antagonist | |||
| 0.031 | 0.025 | 0.031 | GHS receptor antagonist | |||
| 0.053 | 0.047 | 0.053 | Dopamine D4 antagonist | |||
| 0.035 | 0.03 | 0.035 | Diamine oxidase inhibitor | |||
| 0.019 | 0.014 | 0.019 | Somatostatin 3 agonist | |||
| 0.031 | 0.027 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.071 | 0.067 | 0.071 | Histamine H1 receptor antagonist | |||
| 0.031 | 0.026 | 0.031 | Protein kinase C beta II inhibitor | |||
| 0.072 | 0.067 | 0.097 | Interferon agonist | 0.097 0.031 CID_154699906 | CID_154699906 | |
| 0.07 | 0.066 | 0.07 | Estrogen receptor alpha antagonist | |||
| 0.074 | 0.07 | 0.074 | I kappa B kinase inhibitor | |||
| 0.05 | 0.047 | 0.05 | Bombesin 3 receptor antagonist | |||
| 0.06 | 0.057 | 0.06 | Calcium channel P-type blocker | |||
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.017 | 0.015 | 0.017 | Melatonin 1 antagonist | |||
| 0.035 | 0.033 | 0.035 | Substance P antagonist | |||
| 0.015 | 0.013 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.047 | 0.045 | 0.047 | CXC chemokine 1 receptor antagonist | |||
| 0.039 | 0.038 | 0.039 | 5 Hydroxytryptamine 2C agonist | |||
| 0.126 | 0.133 | 0.198 | Interleukin 6 antagonist | 0.198 0.042 CID_154699906 | CID_154699906 | |
| 0.06 | 0.07 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 CID_154699906 | CID_154699906 | |
| 0.054 | 0.071 | 0.071 | Interferon inducer | 0.071 0.034 CID_154699906 | CID_154699906 | |
| 0.102 | 0.121 | 0.175 | DNA repair enzyme inhibitor | 0.175 0.015 CID_154699906 | CID_154699906 | |
| 0.043 | 0.063 | 0.052 | Leukotriene B4 antagonist | 0.052 0.04 CID_154699906 | CID_154699906 | |
| 0.019 | 0.042 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 CID_154699906 | CID_154699906 | |
| 0.071 | 0.098 | 0.132 | Triose-phosphate isomerase inhibitor | 0.132 0.026 CID_154699906 | CID_154699906 | |
| 0.081 | 0.11 | 0.116 | DNA polymerase I inhibitor | 0.116 0.072 CID_154699906 | CID_154699906 | |
| 0.073 | 0.105 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 CID_154699906 | CID_154699906 | |
| 0.064 | 0.096 | 0.091 | Falcipain 2 inhibitor | 0.091 0.058 CID_154699906 | CID_154699906 | |
| 0.066 | 0.098 | 0.093 | Falcipain inhibitor | 0.093 0.06 CID_154699906 | CID_154699906 | |
| 0.076 | 0.114 | 0.105 | Interleukin 12 antagonist | 0.105 0.046 CID_154699906 | CID_154699906 | |
| 0.014 | 0.055 | 0.04 | Protein 30S ribosomal subunit inhibitor | 0.04 0.01 CID_154699906 | CID_154699906 | |
| 0.221 | 0.271 | 0.325 | 5 Hydroxytryptamine release inhibitor | 0.325 0.138 CID_154699906 | CID_154699906 | |
| 0.078 | 0.13 | 0.091 | Folate antagonist | 0.091 0.084 CID_154699906 | CID_154699906 | |
| 0.064 | 0.125 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 CID_154699906 | CID_154699906 | |
| 0.027 | 0.089 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.018 CID_154699906 | CID_154699906 | |
| 0.068 | 0.134 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.07 CID_154699906 | CID_154699906 | |
| 0.068 | 0.135 | 0.085 | T cell inhibitor | 0.085 0.048 CID_154699906 | CID_154699906 | |
| 0.085 | 0.152 | 0.26 | Thrombolytic | 0.26 0.031 CID_154699906 | CID_154699906 | |
| 0.095 | 0.168 | 0.188 | Hexokinase inhibitor | 0.188 0.043 CID_154699906 | CID_154699906 | |
| 0.01 | 0.085 | 0.056 | Sodium/glucose cotransporter 2 inhibitor | 0.056 0.005 CID_154699906 | CID_154699906 | |
| 0.014 | 0.088 | 0.051 | Sodium/glucose cotransporter inhibitor | 0.051 0.005 CID_154699906 | CID_154699906 | |
| 0.063 | 0.14 | 0.096 | Thioredoxin inhibitor | 0.096 0.054 CID_154699906 | CID_154699906 | |
| 0.011 | 0.088 | 0.023 | Motilin receptor agonist | 0.023 0.016 CID_154699906 | CID_154699906 | |
| 0.033 | 0.117 | 0.15 | Antineoplastic antibiotic | 0.15 0.031 CID_154699906 | CID_154699906 | |
| 0.029 | 0.115 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 CID_154699906 | CID_154699906 | |
| 0.047 | 0.135 | 0.125 | Monophenol monooxygenase inhibitor | 0.125 0.058 CID_154699906 | CID_154699906 | |
| 0.162 | 0.251 | 0.34 | Alpha-glucosidase inhibitor | 0.34 0.14 CID_154699906 | CID_154699906 | |
| 0.095 | 0.19 | 0.292 | Nitric oxide antagonist | 0.292 0.042 CID_154699906 | CID_154699906 | |
| 0.018 | 0.113 | 0.045 | Phosphorylase inhibitor | 0.045 0.033 CID_154699906 | CID_154699906 | |
| 0.02 | 0.12 | 0.062 | Mannosidase inhibitor | 0.062 0.015 CID_154699906 | CID_154699906 | |
| 0.107 | 0.213 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 CID_154699906 | CID_154699906 | |
| 0.155 | 0.261 | 0.207 | Caspase 3 stimulant | 0.207 0.16 CID_154699906 | CID_154699906 | |
| 0.022 | 0.133 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.091 0.016 CID_154699906 | CID_154699906 | |
| 0.025 | 0.144 | 0.066 | Phosphofructokinase-1 inhibitor | 0.066 0.051 CID_154699906 | CID_154699906 | |
| 0.024 | 0.144 | 0.325 | Selectin antagonist | 0.325 0.005 CID_154699906 | CID_154699906 | |
| 0.086 | 0.206 | 0.203 | NOS3 expression enhancer | 0.203 0.04 CID_154699906 | CID_154699906 | |
| 0.063 | 0.187 | 0.118 | Alpha-N-acetylglucosaminidase inhibitor | 0.118 0.08 CID_154699906 | CID_154699906 | |
| 0.141 | 0.268 | 0.424 | Immunosuppressant | 0.424 0.055 CID_154699906 | CID_154699906 | |
| 0.027 | 0.161 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.072 0.015 CID_154699906 | CID_154699906 | |
| 0.076 | 0.211 | 0.206 | Cell wall synthesis inhibitor | 0.206 0.028 CID_154699906 | CID_154699906 | |
| 0.064 | 0.201 | 0.182 | Cyclooxygenase 3 inhibitor | 0.182 0.027 CID_154699906 | CID_154699906 | |
| 0.092 | 0.231 | 0.148 | Interferon gamma antagonist | 0.148 0.081 CID_154699906 | CID_154699906 | |
| 0.019 | 0.162 | 0.065 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_154699906 | CID_154699906 | |
| 0.151 | 0.295 | 0.37 | Interleukin 2 agonist | 0.37 0.037 CID_154699906 | CID_154699906 | |
| 0.071 | 0.217 | 0.14 | Protein kinase stimulant | 0.14 0.075 CID_154699906 | CID_154699906 | |
| 0.083 | 0.234 | 0.34 | Hepatoprotectant | 0.34 0.02 CID_154699906 | CID_154699906 | |
| 0.119 | 0.283 | 0.302 | Cholesterol antagonist | 0.302 0.09 CID_154699906 | CID_154699906 | |
| 0.05 | 0.218 | 0.163 | Amylase inhibitor | 0.163 0.058 CID_154699906 | CID_154699906 | |
| 0.025 | 0.2 | 0.084 | Heparanase inhibitor | 0.084 0.005 CID_154699906 | CID_154699906 | |
| 0.039 | 0.229 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 CID_154699906 | CID_154699906 | |
| 0.036 | 0.228 | 0.145 | Expectorant | 0.145 0.038 CID_154699906 | CID_154699906 | |
| 0.073 | 0.268 | 0.337 | Platelet adhesion inhibitor | 0.337 0.023 CID_154699906 | CID_154699906 | |
| 0.022 | 0.22 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.043 CID_154699906 | CID_154699906 | |
| 0.075 | 0.281 | 0.258 | Platelet antagonist | 0.258 0.069 CID_154699906 | CID_154699906 | |
| 0.035 | 0.253 | 0.058 | Lipocortins synthesis agonist | 0.058 0.041 CID_154699906 | CID_154699906 | |
| 0.067 | 0.286 | 0.221 | Interleukin agonist | 0.221 0.102 CID_154699906 | CID_154699906 | |
| 0.031 | 0.261 | 0.052 | Adenine nucleotide translocase inhibitor | 0.052 0.049 CID_154699906 | CID_154699906 | |
| 0.046 | 0.289 | 0.137 | Toll-Like receptor 4 antagonist | 0.137 0.029 CID_154699906 | CID_154699906 | |
| 0.082 | 0.344 | 0.502 | Hypoglycemic | 0.502 0.015 CID_154699906 | CID_154699906 | |
| 0.065 | 0.331 | 0.195 | Hemostatic | 0.195 0.035 CID_154699906 | CID_154699906 | |
| 0.089 | 0.358 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 CID_154699906 | CID_154699906 | |
| 0.013 | 0.3 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.014 CID_154699906 | CID_154699906 | |
| 0.053 | 0.393 | 0.175 | Insulin secretagoues | 0.175 0.051 CID_154699906 | CID_154699906 | |
| 0.054 | 0.397 | 0.149 | Non-steroidal antiinflammatory agent | 0.149 0.116 CID_154699906 | CID_154699906 | |
| 0.034 | 0.398 | 0.176 | Anticoagulant | 0.176 0.063 CID_154699906 | CID_154699906 | |
| 0.076 | 0.453 | 0.344 | Immunomodulator | 0.344 0.062 CID_154699906 | CID_154699906 | |
| 0.017 | 0.47 | 0.061 | Factor IXa inhibitor | 0.061 0.026 CID_154699906 | CID_154699906 | |
| 0.031 | 0.553 | 0.098 | Transcription factor NF kappa B stimulant | 0.098 0.04 CID_154699906 | CID_154699906 | |
| 0.074 | 0.602 | 0.599 | Antiinflammatory | 0.599 0.054 CID_154699906 | CID_154699906 | |
| 0.049 | 0.643 | 0.604 | Cyclophilin D inhibitor | 0.604 0.027 CID_154699906 | CID_154699906 | |
| 0.018 | 0.631 | 0.143 | Cell adhesion inhibitor | 0.143 0.051 CID_154699906 | CID_154699906 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |